Bring new cell and gene therapies to market faster.
The growth of cell and gene therapies signals disruption for the entire healthcare ecosystem, requiring new thinking around development, administration, value, and reimbursement. IQVIA can help you develop and commercialize your therapy, and get ready for what's next.
Support with a proven track record
iqvia's experience with cell and gene therapies extends across a range of clients, from academics to emerging biotech and established pharmaceutical companies. We are uniquely positioned to help you
- Develop a strategic GMP manufacturing plan这降低了复杂性，时间和风险
- 执行临床试验，including identifying sites suitable for advanced therapies and recruiting hard-to-find patients
- Prepare a target product profile(TPP) to guide the development plan and communicate product attributes to stakeholders
- 制定监管策略促进成功的预定/IND会议加急计划（例如，RMAT）
- Prepare evidence for pricing and reimbursementto navigate market access and uptake barriers
用IQVIA Core为试验供电手机版必威
With the IQVIA CORE, our team puts deep therapeutic and scientific expertise, unparalleled data, advanced analytics, and technology, all within reach. So you can meet the challenges of developing your therapy, and learn more about what lies ahead.
And to maximize the expertise we bring to your project, we also believe in connecting with other leaders in the field.
链接信息和见解betway必威怎么提款
Cell and Gene Therapy Center Strategic Partners:
Leverage a global network of Phase I clinical pharmacology units to build diversity in patient populations and access a range of geographic regions for early clinical development (ECD) programs.
通过IQVIA核心的力量提高临床试验的性能。手机版必威
Discover unrealized connections and manage your product across the entire lifecycle, from research and development, compliance to launch and commercialization.
使用先进的分析来评估您针对现实世界证据的协议，并降低昂贵修订的风险。
Identify the best performing sites for your trial in less time with new machine learning and predictive modeling methods.
使用数据驱动的患者招聘解决方案可以更准确地预测入学率，并增加每个部位的患者数量。